Q: What is Omalizumab used for?

Omalizumab is used to treat: Asthma Chronic spontaneous urticaria Chronic rhinosinusitis with nasal polyps

Q: How does Omalizumab work?

Mechanism of Action Omalizumab is a laboratory-made monoclonal antibody designed to target and bind to immunoglobulin E (IgE). IgE is a type of antibody produced by the immune system that plays a key role in allergic responses. In people with allergic asthma, chronic hives, or food allergies, the immune system produces IgE in response to triggers like pollen, pet dander, or specific proteins in food. Omalizumab works through the following steps: Binding to IgE: The medication circulates in the blood and attaches to free IgE molecules before they can cause a reaction. Blocking Immune Cell Activation: By binding to IgE, omalizumab prevents the IgE from attaching to receptors on the surface of specific immune cells, such as mast cells and basophils. Reducing Chemical Release: Because the IgE cannot attach to these immune cells, the cells do not release histamine and other inflammatory chemicals that lead to symptoms like wheezing, swelling, and itching. By lowering the levels of free IgE in the body, omalizumab helps dampen the immune system's overreaction to allergens. This process helps reduce the frequency of asthma attacks and limits the severity of allergic reactions caused by accidental exposure to trigger foods.

Q: What are the brand names for Omalizumab?

Omalizumab is sold under the brand name Xolair .

Q: What are the active ingredients in Omalizumab?

The active ingredient in Omalizumab is omalizumab .

Q: What are the side effects of Omalizumab?

Common side effects of Omalizumab may include: injection site reactions headache fatigue Always consult with a healthcare professional about potential side effects.

Q: What is the dosage of Omalizumab and how do I take it?

Administration Omalizumab is given as a subcutaneous injection (under the skin). It is usually administered once every two weeks or once every four weeks. The frequency of the injections depends on the condition being treated and the results of specific blood tests performed by a healthcare provider. Initial doses are typically given by a healthcare professional in a medical setting, such as a doctor's office or clinic, so the patient can be monitored for any immediate reactions. Depending on the specific product and the patient's history, a doctor may eventually determine that the medication can be administered at home by the patient or a caregiver using a prefilled syringe or autoinjector. Injection Tips Common injection sites include the front of the thigh or the abdomen. If a caregiver is administering the injection, the outer area of the upper arm may also be used. Rotate the injection site with each dose. Avoid injecting into skin that is tender, bruised, red, or hard. If the medication is stored in the refrigerator, it should be removed and allowed to reach room temperature before use. This usually takes about 15 to 30 minutes. Do not shake the medication. Shaking can damage the drug and make it less effective. Missed Dose If you miss an appointment for an injection or forget to take a scheduled dose at home, contact your healthcare provider immediately to reschedule. Do not take a double dose to make up for a missed one.

Q: Is Omalizumab safe during pregnancy and breastfeeding?

Pregnancy There is limited information regarding the safety of omalizumab use during pregnancy. While animal studies have not shown evidence of harm to the fetus, there are no adequate and well-controlled studies in humans. Because untreated asthma or other allergic conditions can pose risks to both the mother and the baby, healthcare providers must weigh the benefits of treatment against any potential risks. If you are pregnant or planning to become pregnant, discuss your treatment plan with your doctor. If you become pregnant while using omalizumab, notify your healthcare provider immediately. You may be encouraged to enroll in a pregnancy registry, which monitors the health of mothers and babies to collect more information about the effects of the medication during pregnancy. Breastfeeding It is not fully known if omalizumab passes into human breast milk or how it might affect a nursing infant. Some clinical evidence suggests that the risk to the infant may be minimal, but because many medications are excreted in breast milk, caution is advised. You should consult your doctor to determine if the benefits of breastfeeding outweigh the potential risks to the infant while you are receiving this medication.

Question 1

What is Omalizumab?

Accepted Answer

Omalizumab is a laboratory-made protein known as a monoclonal antibody. It works by binding to immunoglobulin E (IgE), a substance naturally produced by the immune system that plays a key role in allergic responses.

By attaching to IgE, the medication prevents it from triggering the release of chemicals that cause inflammation and allergic symptoms.

Question 2

What is Omalizumab used for?

Accepted Answer

Omalizumab is used to treat:

Asthma
Chronic spontaneous urticaria
Chronic rhinosinusitis with nasal polyps

Question 3

How does Omalizumab work?

Accepted Answer

Mechanism of Action

Omalizumab is a laboratory-made monoclonal antibody designed to target and bind to immunoglobulin E (IgE). IgE is a type of antibody produced by the immune system that plays a key role in allergic responses.

In people with allergic asthma, chronic hives, or food allergies, the immune system produces IgE in response to triggers like pollen, pet dander, or specific proteins in food. Omalizumab works through the following steps:

Binding to IgE: The medication circulates in the blood and attaches to free IgE molecules before they can cause a reaction.
Blocking Immune Cell Activation: By binding to IgE, omalizumab prevents the IgE from attaching to receptors on the surface of specific immune cells, such as mast cells and basophils.
Reducing Chemical Release: Because the IgE cannot attach to these immune cells, the cells do not release histamine and other inflammatory chemicals that lead to symptoms like wheezing, swelling, and itching.

By lowering the levels of free IgE in the body, omalizumab helps dampen the immune system's overreaction to allergens. This process helps reduce the frequency of asthma attacks and limits the severity of allergic reactions caused by accidental exposure to trigger foods.

Question 4

What are the brand names for Omalizumab?

Accepted Answer

Omalizumab is sold under the brand name Xolair.

Question 5

What are the active ingredients in Omalizumab?

Accepted Answer

The active ingredient in Omalizumab is omalizumab.

Question 6

What are the side effects of Omalizumab?

Accepted Answer

Common side effects of Omalizumab may include:

injection site reactions
headache
fatigue

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Omalizumab?

Accepted Answer

Omalizumab belongs to the monoclonal antibody against IgE drug class.

Question 8

What is the dosage of Omalizumab and how do I take it?

Accepted Answer

Administration

Omalizumab is given as a subcutaneous injection (under the skin). It is usually administered once every two weeks or once every four weeks. The frequency of the injections depends on the condition being treated and the results of specific blood tests performed by a healthcare provider.

Initial doses are typically given by a healthcare professional in a medical setting, such as a doctor's office or clinic, so the patient can be monitored for any immediate reactions. Depending on the specific product and the patient's history, a doctor may eventually determine that the medication can be administered at home by the patient or a caregiver using a prefilled syringe or autoinjector.

Injection Tips

Common injection sites include the front of the thigh or the abdomen. If a caregiver is administering the injection, the outer area of the upper arm may also be used.
Rotate the injection site with each dose. Avoid injecting into skin that is tender, bruised, red, or hard.
If the medication is stored in the refrigerator, it should be removed and allowed to reach room temperature before use. This usually takes about 15 to 30 minutes.
Do not shake the medication. Shaking can damage the drug and make it less effective.

Missed Dose

If you miss an appointment for an injection or forget to take a scheduled dose at home, contact your healthcare provider immediately to reschedule. Do not take a double dose to make up for a missed one.

Question 9

Is Omalizumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the safety of omalizumab use during pregnancy. While animal studies have not shown evidence of harm to the fetus, there are no adequate and well-controlled studies in humans. Because untreated asthma or other allergic conditions can pose risks to both the mother and the baby, healthcare providers must weigh the benefits of treatment against any potential risks.

If you are pregnant or planning to become pregnant, discuss your treatment plan with your doctor. If you become pregnant while using omalizumab, notify your healthcare provider immediately. You may be encouraged to enroll in a pregnancy registry, which monitors the health of mothers and babies to collect more information about the effects of the medication during pregnancy.

Breastfeeding

It is not fully known if omalizumab passes into human breast milk or how it might affect a nursing infant. Some clinical evidence suggests that the risk to the infant may be minimal, but because many medications are excreted in breast milk, caution is advised. You should consult your doctor to determine if the benefits of breastfeeding outweigh the potential risks to the infant while you are receiving this medication.

Question 10

What forms and strengths does Omalizumab come in?

Accepted Answer

Omalizumab is administered as an injection under the skin (subcutaneously). It is available in the following delivery systems:

Prefilled Syringe: A syringe containing the medication in liquid form, used for manual injection.
Autoinjector: A device containing the medication in liquid form, designed to automate the injection process for patients or caregivers.
Vial: A container of lyophilized (freeze-dried) powder that must be reconstituted into a liquid by a healthcare professional before administration.

Question 11

What is the FDA approval status of Omalizumab?

Accepted Answer

FDA Approval and Indications

Omalizumab is approved by the U.S. Food and Drug Administration (FDA) for several specific conditions involving the immune system:

Asthma: For adults and children 6 years of age and older with moderate to severe persistent asthma whose symptoms are not well controlled by inhaled corticosteroids and who have a positive skin or blood test for year-round allergens.
Chronic Spontaneous Urticaria (CSU): For adults and adolescents 12 years of age and older with chronic hives that do not have a known cause and continue despite treatment with H1 antihistamines.
Nasal Polyps: For adults 18 years of age and older as an add-on maintenance treatment when nasal corticosteroids have not worked well enough.
Food Allergies: For adults and children 1 year of age and older to help reduce the risk of allergic reactions, including anaphylaxis, that may occur after accidental exposure to one or more foods. It is not intended for the emergency treatment of allergic reactions.

Boxed Warning

The FDA has issued a boxed warning for omalizumab because it can cause anaphylaxis, a sudden and life-threatening allergic reaction. This reaction can happen after the first dose or after many doses, and it may occur immediately or several hours after the injection. Because of this risk, healthcare providers must monitor patients closely after administration, and patients are often prescribed an epinephrine auto-injector for emergency use.

Regulatory History and Safety

Omalizumab was first approved in 2003. In 2014, the FDA added information to the label regarding a potential increased risk of serious cardiovascular and cerebrovascular events, such as heart disease or stroke, based on a safety review. It remains a prescription-only biologic medication administered by subcutaneous injection.

Question 12

What should I know about Omalizumab and cost?

Accepted Answer

Factors Affecting Cost

The total expense for omalizumab treatment is influenced by several factors related to the prescription and administration process:

Administration Setting: Omalizumab is typically administered by a healthcare professional in a medical office or clinic, which may involve additional costs for the visit and the injection procedure. Some patients may be eligible to self-inject at home after receiving training, which can change the associated costs.
Dosage and Frequency: The dose is often determined by the patient's body weight and specific lab results, such as immunoglobulin E (IgE) levels. Patients requiring higher doses or more frequent injections (every 2 to 4 weeks) will face higher overall costs.
Insurance Coverage: Most insurance plans cover omalizumab, but the patient's out-of-pocket responsibility, such as copays or coinsurance, depends on the specific terms of their policy.

Financial Assistance

Patients may be able to access financial support to help manage the costs of this medication:

Copay Cards: The manufacturer may offer copay cards for patients with commercial insurance to help lower out-of-pocket expenses.
Patient Assistance Programs: There are programs available for patients who are uninsured or underinsured to help them obtain the medication at a reduced cost or for free, provided they meet certain eligibility requirements.

Omalizumab

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Omalizumab

Hospitals.net Disclosure